Internal Medicine
Review: Postoperative pain management in enhanced recovery pathways.
27 Jan, 2022 | 09:24h | UTCPostoperative Pain Management in Enhanced Recovery Pathways – Journal of Pain Research
Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach.
27 Jan, 2022 | 09:18h | UTC
Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.
26 Jan, 2022 | 02:23h | UTCRelated:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Cohort study: Among patients who survived ICU treatment for COVID-19, 75% still reported physical, mental, or cognitive symptoms after 1 year.
26 Jan, 2022 | 02:28h | UTCCommentaries:
75% of COVID ICU survivors have physical symptoms 1 year on – CIDRAP
Majority of COVID-19 survivors experience health problems one-year post ICU admission – News Medical
USPSTF Recommendation Statement: Still not enough evidence to recommend atrial fibrillation screening.
26 Jan, 2022 | 02:08h | UTCAuthor Interview: USPSTF Recommendation: Screening for Atrial Fibrillation – JAMA
Editorials:
Screening for Atrial Fibrillation—More Data Still Needed – JAMA
Screening for Atrial Fibrillation—New Devices, Same Challenges – JAMA Internal Medicine
Screening for Atrial Fibrillation—Refining the Target – JAMA Network Open
JAMA Patient Page: Screening for Atrial Fibrillation
Commentary: USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking – TCTMD
Opinion: Preventing SARS-CoV-2 transmission in health care settings in the context of the Omicron variant.
26 Jan, 2022 | 02:14h | UTC
Commentary on Twitter
Our new piece in @JAMA_current
Transmission of #SARSCoV2 in healthcare settings is a serious concern
We outline three ways hospitals can better prepare for surges— mandating boosters, increasing frequency of testing, & upgrading to N95 maskshttps://t.co/2xRKdKPlhO pic.twitter.com/y0L4UzUNSo
— Abraar Karan (@AbraarKaran) January 24, 2022
Guidelines on the management of Type B aortic dissection.
26 Jan, 2022 | 02:06h | UTCNews Release: New practice guideline addresses diagnosis, treatment of type B aortic dissection – The Society of Thoracic Surgeons
[Preprint] High prevalence of olfactory disorders 18 months after contracting COVID-19.
26 Jan, 2022 | 02:11h | UTCHigh prevalence of olfactory disorders 18 months after contracting COVID-19 – medRxiv
Commentaries:
Half of first-wave Covid cases may have lasting harm to sense of smell – The Guardian
Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection – News Medical
RCT: Acetazolamide prevents adverse altitude effects in COPD and healthy adults.
26 Jan, 2022 | 01:53h | UTCAcetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults – NEJM Evidence
RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment.
26 Jan, 2022 | 01:58h | UTC
Commentary on Twitter
In this 2-year study, data showed that electronic directly observed therapy (eDOT) was as effective as traditional in-person DOT for ensuring high adherence to treatment of tuberculosis disease. @CDC_TB @nycHealthy @ColumbiaMed https://t.co/yTrU1JRuwn pic.twitter.com/QXthE4d266
— JAMA Network Open (@JAMANetworkOpen) January 20, 2022
A registry study with 1,581 cases of Stenotrophomonas maltophilia blood and/or lower respiratory infections suggest Levofloxacin is a reasonable alternative to standard therapy with Trimethoprim-sulfamethoxazole.
26 Jan, 2022 | 01:40h | UTC
Commentary on Twitter
A new study in OFID suggests that mortality outcomes are similar comparing levofloxacin and TMP/SMX treatment of S. maltophilia lower respiratory tract and bloodstream infections.
📄:https://t.co/80QDy3DTU9 #IDSAJournals @PaulSaxMD @DrJLi @Keith_S_Kaye @SameerKadri12 pic.twitter.com/TNxQpfT97n
— IDSA (@IDSAInfo) January 23, 2022
An artificial intelligence system can help predict myocardial infarction through retinal scans and minimal personal information.
26 Jan, 2022 | 01:44h | UTCNews release: Using the eye as a window into heart disease – University of Leeds
Original study: Predicting myocardial infarction through retinal scans and minimal personal information – Nature Machine Intelligence (link to abstract – $ for full-text)
Fever of unknown origin and incidence of cancer: a population-based cohort study using nationwide Danish registries showed that cancer risk in one year was 1.2%.
26 Jan, 2022 | 01:36h | UTCFever of unknown origin and incidence of cancer – Clinical Infectious Diseases (link to abstract – $ for full-text)
Systematic Review: Ultrafiltration for acute heart failure.
26 Jan, 2022 | 01:33h | UTCUltrafiltration for acute heart failure – Cochrane Library
Commentary: Fluid removal therapy in acute heart failure – Cochrane Library
Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold.
26 Jan, 2022 | 01:31h | UTCOral antihistamine‐decongestant‐analgesic combinations for the common cold – Cochrane Library
Commentary: Oral antihistamine-decongestant-analgesic combinations for the common cold – Cochrane Library
Supplement: Irritable bowel syndrome and related conditions.
26 Jan, 2022 | 01:21h | UTCHomepage: IBS and Related Conditions – Alimentary Pharmacology and Therapeutics
Review article: epidemiology of IBS and other bowel disorders of gut–brain interaction (DGBI)
Review article: Physical and psychological comorbidities associated with irritable bowel syndrome
Review article: Diagnosis and investigation of irritable bowel syndrome
Review article: current and future treatment approaches for IBS with constipation
Review article: current and future treatment approaches for pain in IBS
RCT: CPAP improved outcomes in patients with acute hypoxemic respiratory failure due to COVID-19, but high-flow nasal oxygen was not better than conventional oxygen therapy.
25 Jan, 2022 | 09:50h | UTCEditorial: Defining Optimal Respiratory Support for Patients With COVID-19 – JAMA
Commentary on Twitter
RCT of patients with acute hypoxemic respiratory failure due to #COVID19 found an initial strategy of CPAP, compared with conventional oxygen therapy, significantly reduced the composite outcome of tracheal intubation or mortality within 30 days. https://t.co/fznFigiFmu pic.twitter.com/b7mHssbfkp
— JAMA (@JAMA_current) January 24, 2022
ACP living, rapid review: risk for reinfection after SARS-CoV-2.
25 Jan, 2022 | 09:47h | UTC
Commentary on Twitter
Risk for Reinfection After #SARSCoV2: previous infection reduced risk for reinfection by 87% (95% CI, 84% to 90%). Protection remained above 80% for at least 7 months, but no study followed patients after the emergence of the Delta or #Omicron variant. https://t.co/eruEf1w8Vo
— Prof. Nick Talley (@Prof_NickTalley) January 25, 2022
WHO drops opposition to boosters – recommends third Pfizer jab for adults & two vaccines for children ages 5 & up.
25 Jan, 2022 | 09:45h | UTCRelated:
WHO updated roadmap for prioritizing uses of COVID-19 vaccines.
WHO advisers weigh in on COVID-19 boosters, Pfizer vaccine in younger kids.
A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.
25 Jan, 2022 | 09:43h | UTCNews release: BNT162b2 COVID-19 vaccine associated with increased risk of carditis – American College of Physicians
Related:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa.
25 Jan, 2022 | 09:41h | UTCCommentary: Omicron severity: milder but not mild – The Lancet
Commentary on Twitter
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in S. Africa, Lancet. Individuals with Omicron vs previous infections 80% lower odds of being admitted to hospital, 70% lower odds of severe disease than Deltahttps://t.co/528NWfKrDN
— Monica Gandhi MD, MPH (@MonicaGandhi9) January 23, 2022
[Preprint] Cohort study: Reduced risk of hospitalization associated with infection with SARS-CoV-2 Omicron relative to Delta.
25 Jan, 2022 | 09:40h | UTCCommentaries:
Danish report: lower risk of hospitalisation with Omicron – Copenhagen Post
Commentary on Twitter
New Danish population-based cohort study confirms lower (36%, 95%CI 44%-25%) risk of hospitalization with Omicron compared with Delta.
The risk also seems to be reduced irrespective of vaccination status.Pre-print can be found here: https://t.co/LfRrw1H3CY pic.twitter.com/Ql3zPyZyRE
— Anders Husby (@a_husby) January 20, 2022
[Preprint] Omicron SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta.
25 Jan, 2022 | 09:37h | UTC
Commentary on Twitter
In Portugal, Omicron hospitalizations were 75% reduced compared with Delta, risk adjusted. Vaccination reduced hospitalizations 84%, w/a booster 93%https://t.co/MvkfuF3mzx pic.twitter.com/zyk2INWNis
— Eric Topol (@EricTopol) January 23, 2022
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
25 Jan, 2022 | 09:25h | UTC
Review: Diagnosis and management of functional neurological disorder.
25 Jan, 2022 | 09:22h | UTCDiagnosis and management of functional neurological disorder – The BMJ